← Leaderboards
Hui Zhong
New York Blood Center
$1,617,308
Attributed
$3,234,616
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $815.6K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,234,616 · 2
By mechanism
R01$2,430,616 · 1
R56$804,000 · 1
Top collaborators
- Xiuli An4 shared
Most similar at New York Blood Center
Same institution · by research overlap
- Xiuli An$8,630,004
- Karina Yazdanbakhsh$18,887,767
- Cheryl Ann Lobo$8,181,413
- Francesca Vinchi$2,442,808
- Shan Su$427,000
Others in their field
Other Rising Stars on “Erythroblasts”
- Soroush Tahmasebi · University Of Illinois At Chicago$1,909,206
- Katie Giger Seu · Cincinnati Childrens Hosp Med Ctr$455,955
- Jing Yang · Aplexis, Inc.$397,198
- Jennell White · Wayne State University$303,192
- Honghao Bi · Northwestern University At Chicago$248,996
- Matthew Robert Gazzara · University Of Pennsylvania$136,362
Research focus
ErythroblastsErythroid CellsDefectCrosslinkErythrocyte TransfusionErythroidAcuteBiological MarkersComplicationAntibodiesEpor GeneErythrocytesAdultEffective TherapyAnemiaCell AgeCell Culture SystemCell LineCellsBlocking AntibodiesCessation Of LifeCfu-EAutologousErythrophagocytosis
Grant awards (4)
Transfusion-driven hyperhemolysis in sickle cell disease$815,643
R01 · FY2025 · HL
Transfusion-driven hyperhemolysis in sickle cell disease$799,330
R01 · FY2024 · HL
Transfusion-driven hyperhemolysis in sickle cell disease$815,643
R01 · FY2023 · HL
Transfusion-driven hyperhemolysis in sickle cell disease$804,000
R56 · FY2022 · HL